Lin, Dong-Fang <br/><br/>
Linezolid for the treatment of infections caused by Gram-positive pathogens in China.  [electronic resource] 

 -  International journal of antimicrobial agents  Sep 2008 
 - 241-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0924-8579 
<br/><br/><label>Standard No.: </label>10.1016/j.ijantimicag.2008.04.004  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acetamides--administration & dosage<br/>Adolescent<br/>Adult<br/>Aged<br/>Anti-Bacterial Agents--administration & dosage<br/>China<br/>Cross Infection--drug therapy<br/>Double-Blind Method<br/>Female<br/>Gram-Positive Bacterial Infections--drug therapy<br/>Gram-Positive Cocci--drug effects<br/>Humans<br/>Linezolid<br/>Male<br/>Middle Aged<br/>Oxazolidinones--administration & dosage<br/>Pneumonia, Bacterial--drug therapy<br/>Skin Diseases, Bacterial--drug therapy<br/>Soft Tissue Infections--drug therapy<br/>Treatment Outcome<br/>Vancomycin--administration & dosage